GLP-1 drugs like Ozempic suppress hunger but carry serious risks: accelerated muscle loss, gastroparesis, and worsening age-related decline. The speaker weighs these against obesity's dangers and says protein and resistance training can offset muscle loss if you manage the risks carefully.
Yes. You mentioned the sarcopenia. People lose muscle mass, and one of the prime indicators of aging is a, a certain amount of muscle mass loss. Like, one of the things that characterizes HIV turning into AIDS and AIDS going from manageable to fatal is a certain loss of muscle mass. Like, when people lose a certain degree of muscle mass, they're dead. They, they're, they're just done. And And this is kind of what happens with us in the aging process. So if you've got a drug that really enhances loss of muscle, enhances sarcopenia, it's concerning. But like, so we've got, those are some of the big side effects, like the gastroparesis, the, the, the, I guess like the, the motility, and then also the loss of muscle mass, sarcopenia. The flip side though, like what we were talking about. Yeah, let's talk about that. We know that obesity is dangerous, like really, really, you know, pan— you know, 10, 10 alarm fire dangerous. So I don't know who's right, like any given individual, is it gonna be a net win? Is it gonna be a net loss? If you're the person that ends up with gastroparesis, it's probably gonna be bad. But also if you were 5'2 and 350 pounds, like life was probably going to be short and difficult. So, this is kind of where I am with this stuff is that I think people need to understand that there are potential downsides. Like, it's not a free lunch. It's not without its risks. You may be the person that it works great and you do the smart things where you continue to eat enough protein and you lift some weights. And my goodness, you get like a shockingly great transformation, you know.
